Electra Therapeutics, Inc.

ETRA chart

Electra Therapeutics, Inc. news

• This FirstEnergy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

  Benzinga · Oct 26, 7:57 AM EDT

• Electra Therapeutics, Inc. Estimates – NASDAQ:ETRA

  TradingView · Oct 23, 10:46 PM EDT

• Star adds $200M after spinout successes

  BioPharma Dive · Oct 23, 12:18 PM EDT

• 12 Health Care Stocks Moving In Friday's Pre-Market Session

  Benzinga · Oct 23, 8:05 AM EDT

• A biotech's $200 million financing will help advance experimental therapies toward human testing.

  Stock Titan · Oct 23, 7:00 AM EDT

• Electra Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | ETRA | US2848251060

  www.marketscreener.com · Oct 23, 5:49 AM EDT

• JPMorgan Initiates Electra Therapeutics at Overweight With $36 Price Target

  Yahoo Finance · Oct 22, 8:26 AM EDT

• Electra Therapeutics, Inc.'s Quiet Period Will Expire on October 28th (NASDAQ:ETRA)

  MarketBeat · Oct 21, 1:44 AM EDT

• Oura Shows How Shaky the IPO Market Really Is

  Yahoo Finance · Sep 30, 8:23 AM EDT

• Electra Therapeutics Announces Pricing of Upsized $350.0 Million Initial Public Offering

  Yahoo Finance · Sep 17, 8:30 PM EDT

Electra Therapeutics, Inc. key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-09-21
• S-1S-12026-08-28

About Electra Therapeutics, Inc.

Ticker

ETRA (Nasdaq)

Industry

Biological Products, (No Diagnostic Substances)

Headquarters

South San Francisco, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

2088082

Frequently asked questions